NeuroVive’s NeuroSTAT Project receives FDA fast track designation

This article was originally published here

NeuroSTAT’s FDA Fast Track designation makes NeuroVive eligible, for example, for more frequent meetings and written communication with the FDA, continuous feedback on each section of its New

The post NeuroVive’s NeuroSTAT Project receives FDA fast track designation appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply